Alan Christy Hunter

Cited by

	All	Since 2019
Citations	15915	4354
h-index	41	27
i10-index	69	42

1300

650

325

975

2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202451 97 120 193 385 463 507 616 692 886 993 1085 1204 1058 1121 1022 922 800 835 820 754 621 518

Public access

View all

11 articles

5 articles

available

not available

Based on funding mandates

Co-authors

SM MoghimiProfessor of Pharmaceutics and Nanomedicine; School of Pharmacy and Institute of Cellular MedicineVerified email at ncl.ac.uk
Thomas L. AndresenProfessor, Technical University of DenmarkVerified email at nanotech.dtu.dk
Adam SzewczykProfessor of Biochemistry, Nencki Institute of Experimental BiologyVerified email at nencki.edu.pl
Janos SzebeniNanomedicine Research and Education Center, Semmelweis UniversityVerified email at seroscience.com
Islam HamadAssociate Professor of NanomedicineVerified email at aum.edu.jo
Andrew LloydProfessor of Biomedical MaterialsVerified email at brighton.ac.uk
Hongjie DaiProfessor of chemistry, stanford universityVerified email at stanford.edu
Simon Paul HardyUniversity of BrightonVerified email at brighton.ac.uk
Dipak K SarkerAssociate Professor in Materials Science, University of BrightonVerified email at brighton.ac.uk
Kenton M SandersUniversity of Nevada, RenoVerified email at med.unr.edu
Gregory M. DickUniversity of North Texas Health Science CenterVerified email at unthsc.edu
Flemming BesenbacherProfessor in nanosceince and physics, Aarhus University; Chairman of the Carlsberg FoundationVerified email at inano.au.dk
Dan PeerProf. of NanoMedicine and Immunology, Tel Aviv UniversityVerified email at post.tau.ac.il
Jonathan D. LippiatUniversity of LeedsVerified email at leeds.ac.uk
İsmail KIRANEskişehir Osmangazi UniversityVerified email at ogu.edu.tr
Richard A. BryceDivision of Pharmacy and Optometry, University of ManchesterVerified email at manchester.ac.uk
Christopher F. BlanfordSenior Lecturer, Univ. Manchester, Dept. of Materials & Manchester Institute of BiotechnologyVerified email at manchester.ac.uk
Fan FeiSchool of Materials, The University of ManchesterVerified email at manchester.ac.uk
Richard WinpennyProfessor of Inorganic Chemistry, The University of ManchesterVerified email at manchester.ac.uk
Dr Steven Meikle

Alan Christy Hunter

Associate Professor in Pharmaceutics (Drug Delivery and Nanomedicine)

Verified email at lincoln.ac.uk

Nanomedicine Complement Biocatalysis Steroids


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Long-circulating and target-specific nanoparticles: theory to practice SM Moghimi, AC Hunter, JC Murray Pharmacological reviews 53 (2), 283-318, 2001	4855	2001
Nanomedicine: current status and future prospects SM Moghimi, AC Hunter, JC Murray The FASEB journal 19 (3), 311-330, 2005	2758	2005
A two-stage poly (ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy SM Moghimi, P Symonds, JC Murray, AC Hunter, G Debska, A Szewczyk Molecular therapy 11 (6), 990-995, 2005	1309	2005
Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective SM Moghimi, AC Hunter, TL Andresen Annual review of pharmacology and toxicology 52 (1), 481-503, 2012	620	2012
Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity AC Hunter Advanced drug delivery reviews 58 (14), 1523-1531, 2006	537	2006
Poloxamers and poloxamines in nanoparticle engineering and experimental medicine SM Moghimi, AC Hunter Trends in biotechnology 18 (10), 412-420, 2000	516	2000
Agricultural robotics: the future of robotic agriculture T Duckett, S Pearson, S Blackmore, B Grieve, WH Chen, G Cielniak, ... arXiv preprint arXiv:1806.06762, 2018	369	2018
Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere− serum interface: implications for stealth nanoparticle engineering I Hamad, O Al-Hanbali, AC Hunter, KJ Rutt, TL Andresen, SM Moghimi ACS nano 4 (11), 6629-6638, 2010	308	2010
Poly (ethylene glycol) s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process I Hamad, AC Hunter, J Szebeni, SM Moghimi Molecular immunology 46 (2), 225-232, 2008	307	2008
Material properties in complement activation SM Moghimi, AJ Andersen, D Ahmadvand, PP Wibroe, TL Andresen, ... Advanced drug delivery reviews 63 (12), 1000-1007, 2011	285	2011
Polycation cytotoxicity: a delicate matter for nucleic acid therapy—focus on polyethylenimine L Parhamifar, AK Larsen, AC Hunter, TL Andresen, SM Moghimi Soft Matter 6 (17), 4001-4009, 2010	260	2010
Capture of stealth nanoparticles by the body’s defences SM Moghimi, C Hunter Critical Reviews™ in Therapeutic Drug Carrier Systems 18 (6), 2001	216	2001
Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups SM Moghimi, AC Hunter Pharmaceutical research 18, 1-8, 2001	200	2001
Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes PP Wibroe, AC Anselmo, PH Nilsson, A Sarode, V Gupta, R Urbanics, ... Nature nanotechnology 12 (6), 589-594, 2017	197	2017
Complement activation cascade triggered by PEG–PL engineered nanomedicines and carbon nanotubes: The challenges ahead SM Moghimi, AJ Andersen, SH Hashemi, B Lettiero, D Ahmadvand, ... Journal of controlled release 146 (2), 175-181, 2010	192	2010
PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance JK Gbadamosi, AC Hunter, SM Moghimi FEBS letters 532 (3), 338-344, 2002	191	2002
Causative factors behind poloxamer 188 (Pluronic F68, Flocor™)-induced complement activation in human sera: A protective role against poloxamer-mediated complement activation … SM Moghimi, AC Hunter, CM Dadswell, S Savay, CR Alving, J Szebeni Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1689 (2), 103-113, 2004	159	2004
Cationic carriers of genetic material and cell death: a mitochondrial tale AC Hunter, SM Moghimi Biochimica et Biophysica Acta (BBA)-Bioenergetics 1797 (6-7), 1203-1209, 2010	153	2010
Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective AC Hunter, J Elsom, PP Wibroe, SM Moghimi Maturitas 73 (1), 5-18, 2012	152	2012
Low and high molecular weight poly (l-lysine) s/poly (l-lysine)–DNA complexes initiate mitochondrial-mediated apoptosis differently P Symonds, JC Murray, AC Hunter, G Debska, A Szewczyk, SM Moghimi FEBS letters 579 (27), 6191-6198, 2005	152	2005

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors